Global

Details

  • Service: Tax, Global Compliance Management Services, International Tax
  • Type: Regulatory update
  • Date: 11/15/2013

China - Expanded R&D-related expenses eligible for “super deduction” 

November 15: China’s Ministry of Finance and the State Administration of Taxation jointly issued guidance that broadens the scope of research and development (R&D) expenses that are eligible for the “super deduction.”

Circular 70 is intended to encourage enterprises to engage in R&D activities by allowing the following items to be considered for the R&D super deduction:


  • Basic pension insurance premiums, basic medical insurance premiums, unemployment insurance premiums, work injury insurance premiums, maternity insurance premiums and housing funds contributed by an enterprise for full-time employees exclusively engaged in R&D activities in accordance with the scope and standards stipulated by the state council or the provincial government
  • Expenses incurred for the maintenance, tuning, inspection, and repair of instruments and equipment used exclusively for R&D activities
  • Expenses incurred for the purchase of samples, prototypes, and general testing items that do not constitute fixed assets
  • Clinical trial expenses for development of new medicine
  • Expenses for evaluation of R&D results

Read a November 2013 report [PDF 369 KB] prepared by the KPMG member firm in China: Scope of R&D Expenses Eligible for Super Deduction Enlarged




©2014 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. All rights reserved.


The KPMG logo and name are trademarks of KPMG International.


KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever.


The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation.


Direct comments, including requests for subscriptions, to us-kpmgwnt@kpmg.com.
For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at:

+ 1 202 533 4366

1801 K Street NW
Washington, DC 20006.

 

Share this

Share this

Subscribe

Subscribe to receive the latest TaxNewsFlash email alerts (you must select the option for TaxNewsFlash)


Already a Subscriber? Login


Not a member? Subscribe now